AI assistant
LABCORP HOLDINGS INC. — Director's Dealing 2021
Feb 8, 2021
30237_dirs_2021-02-08_281b9b52-755f-4fc3-826b-30064e897494.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-02-04
Reporting Person: Wilkinson Peter J (SVP, Chief Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-04 | Common Stock | M | 150 | — | Acquired | 576.2194 | Direct |
| 2021-02-04 | Common Stock | F | 53 | $223.78 | Disposed | 523.2194 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-04 | Restricted Stock Unit | $ | M | 150 | Disposed | Common Stock (150) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: Amount includes 129.2194 shares acquired on June 30, 2020 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
F3: Stock withholding to satisfy tax withholding obligations.
F4: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 4, 2021.
F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.